Get 20% Free Customization In This Report

Buy this report from - $3456

Rapid Diagnostics Market by Product (Over-The-Counter (OTC) Rapid Diagnostics Test, and Professional Rapid Diagnostics Test), and Application (Blood Glucose Rapid Diagnostics, Infectious Diseases Rapid Diagnostics, Cardiometabolic Rapid Diagnostics, Coagulation Rapid Diagnostics, Pregnancy & Fertility Rapid Diagnostics, Fecal Occult Blood Rapid Diagnostics, and Toxicology Rapid Diagnostics) - Global Opportunities and Forecasts, 2017-2023

Diagnostics and Biotech	LI_183752	Pages: NA	Jun 2018 \| 575 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Rapid diagnostic test (RDT) is essentially utilized in preliminary or emergency medical screening along with medical facilities that have limited resources. RDTs enable point-of-care testing in primary care by quick and easy operations. Rapid diagnostics is incorporated in several conventional diagnostics tests such as rapid antibody tests including rapid HIV test, rapid plasma regain, and rapid antigen tests that include rapid influenza diagnostic test & malaria antigen detection tests among others.

Rapid diagnostic tests are highly adopted for diagnosis, patient management, epidemiology, and screening. The major factors that fuel the growth of the market are increase in the demand for rapid diagnostic tests in decentralized settings along with rising awareness regarding early diagnosis among people. In addition, the escalating need for inexpensive diagnostic testing coupled with accuracy raises the market growth. However, lack of awareness regarding newer rapid diagnostic tests available in the market restrains the growth of the rapid diagnostics market. Moreover, the rising demand for bedside diagnostic testing will offer profitable opportunities for the growth of the rapid diagnostics market.

The report segments the market on the basis of product, application, and region. Based on product, the market is divided into over-the-counter (OTC) rapid diagnostics test and professional rapid diagnostics test. Based on application, the market is classified into blood glucose rapid diagnostics, infectious diseases rapid diagnostics, cardiometabolic rapid diagnostics, coagulation rapid diagnostics, pregnancy & fertility rapid diagnostics, fecal occult blood rapid diagnostics, and toxicology rapid diagnostics. Based on region, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in this market are Abaxis, Becton, Dickinson and Company, Bio-Rad Laboratories, Accriva Diagnostics, ACON Laboratories, Inc., Hologic, Inc., Abbott Laboratories, Roche Diagnostics, Bayer HealthCare Pharmaceuticals LLC, and Cepheid Inc.

Key Benefits

The study provides an in-depth analysis of the global rapid diagnostics market, with current trends and future estimations to elucidate imminent investment pockets.
It presents a quantitative analysis from 2016 to 2023 to enable stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of the market by type assists in understanding various forms of rapid diagnostic available.
Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.

Rapid Diagnostics Market Key Segmentation:

By Product

Over-The-Counter (OTC) Rapid Diagnostics Test
Professional Rapid Diagnostics Test

By Application

Blood Glucose Rapid Diagnostics
Infectious Diseases Rapid Diagnostics
Cardiometabolic Rapid Diagnostics
Coagulation Rapid Diagnostics
Pregnancy & Fertility Rapid Diagnostics
Fecal Occult Blood Rapid Diagnostics
Toxicology Rapid Diagnostics

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Argentina
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 GLOBAL RAPID DIAGNOSTICS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. OVER-THE-COUNTER (OTC) RAPID DIAGNOSTICS TEST

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. PROFESSIONAL RAPID DIAGNOSTICS TEST

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Chapter: 5 GLOBAL RAPID DIAGNOSTICS MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. BLOOD GLUCOSE RAPID DIAGNOSTICS

5.2.1. Market size and forecast

5.3. INFECTIOUS DISEASES RAPID DIAGNOSTICS

5.3.1. Market size and forecast

5.4. CARDIOMETABOLIC RAPID DIAGNOSTICS

5.4.1. Market size and forecast

5.5. COAGULATION RAPID DIAGNOSTICS

5.5.1. Market size and forecast

5.6. PREGNANCY & FERTILITY RAPID DIAGNOSTICS

5.6.1. Market size and forecast

5.47 FECAL OCCULT BLOOD RAPID DIAGNOSTICS

5.7.1. Market size and forecast

5.8. TOXICOLOGY RAPID DIAGNOSTICS

5.8.1. Market size and forecast

Chapter: 6 GLOBAL RAPID DIAGNOSTICS MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Rapid Diagnostics Market by Type
6.2.5. North America Rapid Diagnostics Market by Application

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe Rapid Diagnostics Market by Type
6.3.5. Europe Rapid Diagnostics Market by Application

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Rapid Diagnostics Market by Type
6.4.5. Asia-Pacific Rapid Diagnostics Market by Application

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Saudi Arabia market size and forecast
6.5.3.3. Argentina market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast

6.5.4. LAMEA Rapid Diagnostics Market by Type
6.5.5. LAMEA Rapid Diagnostics Market by Application

Chapter: 7 COMPANY PROFILES

7.1. ABAXIS

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. BECTON DICKINSON CO.

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. BIO-RAD LABORATORIES

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. ACCRIVA DIAGNOSTICS

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. ACON LABORATORIES, INC.

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. HOLOGIC, INC.

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. ABBOTT LABORATORIES

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. ROCHE DIAGNOSTICS

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. BAYER HEALTHCARE PHARMACEUTICALS LLC

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. CEPHEID INC.

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.